Literature DB >> 18594824

Complications of laparoscopic retroperitoneal lymph node dissection in testicular cancer.

Patrick A Kenney1, Ingolf A Tuerk.   

Abstract

OBJECTIVES: A proposed benefit of laparoscopic retroperitoneal lymph node dissection (LRPLND) is more favorable morbidity in comparison to open retroperitoneal lymph node dissection (RPLND). The objective of this review is to examine and summarize the literature regarding complications in both primary and post-chemotherapy LRPLND (PC-LRPLND) and, where appropriate, we include the opinions of the senior author regarding management.
METHODS: A MEDLINE search was performed using the terms "laparoscopy" or "laparoscopic," "retroperitoneal lymph node dissection" or "RPLND," and "testicular neoplasms." Articles were included on the basis of study design and content. For series updated over time, an effort was made to include only the most recent data to avoid duplicate reporting of patients.
RESULTS: In primary LRPLND, vascular injury is the most common complication, occurring in 2.2-20% of reported cases. Bowel injury is rarely reported but potentially catastrophic. Rates of retrograde ejaculation are less than 5%. Chylous ascites and lymphocele are delayed post-operative complications. Rarely reported complications include nerve injury, retroperitoneal hematoma, and ureteral injury requiring internal stent placement. PC-LRPLND is challenging, with high rates of conversion and complications. Hemorrhage is common. Retrograde ejaculation is several-fold more common in PC-LRPLND than in primary LRPLND. No peri-operative mortality has been reported for either LRPLND or PC-LRPLND.
CONCLUSIONS: LRPLND and PC-LRPLND are technically demanding. Hemorrhage and vascular injury are the most commonly reported complications. Prospective studies will help clarify the proposed benefits of LRPLND.

Entities:  

Mesh:

Year:  2008        PMID: 18594824     DOI: 10.1007/s00345-008-0299-3

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  31 in total

Review 1.  Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ-cell tumors: current status.

Authors:  Robert J Hamilton; Antonio Finelli
Journal:  Urol Clin North Am       Date:  2007-05       Impact factor: 2.241

2.  Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients.

Authors:  Stephen D W Beck; Matthew D Peterson; Richard Bihrle; John P Donohue; Richard S Foster
Journal:  J Urol       Date:  2007-06-11       Impact factor: 7.450

3.  En bloc nephrectomy in patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous testis cancer: indications, implications and outcomes.

Authors:  P A Nash; I Leibovitch; R S Foster; R Bihrle; R G Rowland; J P Donohue
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

4.  Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer.

Authors:  Nasser Albqami; Günter Janetschek
Journal:  J Endourol       Date:  2005 Jul-Aug       Impact factor: 2.942

5.  Long-term experience with laparoscopic retroperitoneal lymph node dissection in the management of low-stage testis cancer.

Authors:  J J Rassweiler; T Frede; E Lenz; O Seemann; P Alken
Journal:  Eur Urol       Date:  2000-03       Impact factor: 20.096

6.  Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: indications and limitations.

Authors:  J J Rassweiler; O Seemann; T O Henkel; C Stock; T Frede; P Alken
Journal:  J Urol       Date:  1996-09       Impact factor: 7.450

7.  Extraperitoneal laparoscopic para-aortic lymph node dissection for early stage nonseminomatous germ cell tumors of the testis with introduction of a nerve sparing technique: description and results.

Authors:  E LeBlanc; A Caty; D Dargent; D Querleu; E Mazeman
Journal:  J Urol       Date:  2001-01       Impact factor: 7.450

8.  Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors.

Authors:  J B Nelson; R N Chen; J T Bishoff; W K Oh; P W Kantoff; R C Donehower; L R Kavoussi
Journal:  Urology       Date:  1999-12       Impact factor: 2.649

9.  Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer.

Authors:  Ashraf A Mosharafa; Richard S Foster; Michael O Koch; Richard Bihrle; John P Donohue
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

10.  Hand-assisted laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular cancer.

Authors:  Endre Holman; Gábor Kovács; Tibor Flaskó; Csaba Maróti; János Vancsora; Csaba Tóth; Morshed A Salah
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2007-02       Impact factor: 1.878

View more
  13 in total

1.  Extraperitoneal laparoscopic retroperitoneal lymph node dissection after chemotherapy for nonseminomatous testicular germ-cell tumor: surgical and oncological outcomes.

Authors:  Yoichi Arai; Yasuhiro Kaiho; Shigeyuki Yamada; Hideo Saito; Koji Mitsuzuka; Shinichi Yamashita; Shunichi Namiki; Haruo Nakagawa; Shigeto Ishidoya; Akihiro Ito
Journal:  Int Urol Nephrol       Date:  2012-05-22       Impact factor: 2.370

Review 2.  Critical evaluation of modified templates and current trends in retroperitoneal lymph node dissection.

Authors:  Shane Pearce; Zoe Steinberg; Scott Eggener
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

3.  Efficacy of DynaCT for surgical navigation during complex laparoscopic surgery: an initial experience.

Authors:  Tetsuo Nozaki; Yasuyoshi Fujiuchi; Akira Komiya; Hideki Fuse
Journal:  Surg Endosc       Date:  2012-10-06       Impact factor: 4.584

Review 4.  Robotic Primary RPLND for Stage I Testicular Cancer: a Review of Indications and Outcomes.

Authors:  Heather J Chalfin; Wesley Ludwig; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Curr Urol Rep       Date:  2016-05       Impact factor: 3.092

5.  The Effectiveness of a Systematic Algorithm for the Management of Vascular Injuries during the Laparoscopic Surgery.

Authors:  Carlo C Passerotti; José A Cruz; Sabrina T Reis; Marcelo T Okano; Ricardo J Duarte; Miguel Srougi; Hiep T Nguyen
Journal:  Curr Urol       Date:  2016-09-20

6.  Laparoscopic retroperitoneal lymph node dissection for stage I and II nonseminomatous germ-cell tumors.

Authors:  Thomas J Guzzo; Mohamad E Allaf
Journal:  Ther Adv Urol       Date:  2009-06

7.  Postoperative chylous ascites after colorectal cancer surgery.

Authors:  Hideaki Nishigori; Masaaki Ito; Yuji Nishizawa; Atsushi Koyama; Takamaru Koda; Kentaro Nakajima; Nozomi Minagawa; Yusuke Nishizawa; Akihiro Kobayashi; Masanori Sugito; Norio Saito
Journal:  Surg Today       Date:  2012-02-14       Impact factor: 2.549

8.  Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.

Authors:  Terukazu Nakamura; Akihiro Kawauchi; Masakatsu Oishi; Takashi Ueda; Takumi Shiraishi; Hiroyuki Nakanishi; Kazumi Kamoi; Yoshio Naya; Fumiya Hongo; Koji Okihara; Tsuneharu Miki
Journal:  Int J Clin Oncol       Date:  2015-12-23       Impact factor: 3.402

9.  Laparoscopic and open postchemotherapy retroperitoneal lymph node dissection in patients with advanced testicular cancer--a single center analysis.

Authors:  Jonas Busch; Ahmed Magheli; Barbara Erber; Frank Friedersdorff; Ivan Hoffmann; Carsten Kempkensteffen; Steffen Weikert; Kurt Miller; Mark Schrader; Stefan Hinz
Journal:  BMC Urol       Date:  2012-05-31       Impact factor: 2.264

Review 10.  Laparoscopic retroperitoneal lymph node dissection for testicular cancer.

Authors:  Joel H Hillelsohn; Brian D Duty; Zhamshid Okhunov; Louis R Kavoussi
Journal:  Arab J Urol       Date:  2012-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.